PMC:7600245 / 8063-8190 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T47","span":{"begin":84,"end":87},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T48","span":{"begin":113,"end":121},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"The parenterally administered drug is being developed by Gilead Sciences, U.S., and has broad-spectrum antiviral activity [26]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T61","span":{"begin":30,"end":34},"obj":"Chemical"},{"id":"T62","span":{"begin":103,"end":112},"obj":"Chemical"}],"attributes":[{"id":"A61","pred":"chebi_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A62","pred":"chebi_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"The parenterally administered drug is being developed by Gilead Sciences, U.S., and has broad-spectrum antiviral activity [26]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T61","span":{"begin":0,"end":127},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The parenterally administered drug is being developed by Gilead Sciences, U.S., and has broad-spectrum antiviral activity [26]."}